9:02AM Biolase projects that net cash used in operating activities will total $3.5 -4.5 mln for the year ending December 31, 2013 vs $1.7 mln for the year ended December 31, 2012 (BIOL) 1.60 : The primary reasons for BIOLASE's higher cash burn for the year ending December 31, 2013, as compared to the prior year, include the launch of our start-up BIOLASE Da Vinci Imaging Division, the continued investments in expanding our sales force, significant legal expenses in successfully defending and protecting our patent portfolio, and the introduction of a number of new marketing initiatives, including the launch of a consumer campaign to educate the public on the wide advantages of virtually painless and safe WaterLase(R) dentistry versus conventional shot and drill dentistry. All of these initiatives are expected to yield positive results in the second half of 2013. "We also expect that the BIOLASE Da Vinci Imaging Division will produce a positive contribution profit during the second half of 2013 versus a negative contribution profit for the six months ending June 30, 2013. We expect that the BIOLASE Da Vinci Imaging Division will be a substantial contributor of revenues for the year ending December 31, 2013, approaching the 10% of net revenue sales, and that it will grow to a range of $15 million to $20 million of net revenue for the year ending December 31, 2014," concluded Arrow.
Market Data 
Markets 
AI
